Claims for Patent: 10,213,485

✉ Email this page to a colleague

Summary for Patent: 10,213,485

Title:	HGF preparation suitable for treatment of neurological disorders
Abstract:	The present invention provides a hepatocyte growth factor (HGF) preparation in the form of an injection or the like that is highly safe for central nerves and highly stable and can be used for intrathecal or intracerebroventricular administration or for administration into the spinal or cerebral parenchyma for the treatment of central nervous system diseases. The HGF preparation of the present invention contains an HGF protein as an active ingredient and lactose, glycine, sodium chloride, a pH buffering agent and a surfactant as additional ingredients.
Inventor(s):	Kazuhiro Fukuta, Hayao Inoue
Assignee:	Kringle Pharma Inc
Application Number:	US15/507,886

Details for Patent 10,213,485

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Amgen Inc.	VECTIBIX	panitumumab	Injection	125147	September 27, 2006	⤷ Get Started Free	2035-08-27
Alexion Pharmaceuticals, Inc.	STRENSIQ	asfotase alfa	Injection	125513	October 23, 2015	⤷ Get Started Free	2035-08-27
Novo Nordisk Inc.	TRESIBA	insulin degludec	Injection	203314	September 25, 2015	⤷ Get Started Free	2035-08-27
Novo Nordisk Inc.	TRESIBA	insulin degludec	Injection	203314	November 21, 2018	⤷ Get Started Free	2035-08-27
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,213,485

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2016039163	⤷ Get Started Free
United States of America	2019117732	⤷ Get Started Free
United States of America	2017333527	⤷ Get Started Free
United States of America	10702582	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.